Drugs / RGN1016
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02820155 | Jun 2016 → Feb 2017 | — | National Taiwan University Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RGN1016 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02820155 ↗ |
| Route | Oral | “Stage I: single oral dose Stage II: multiple oral dose (QD, 7days)” NCT02820155 ↗ |